Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2012 / Cilt: 22 - Sayı: 1

Evaluatıon of vascular rısk factors ın alzheımer’s dementıa: clınıcal experıence

Alzheimer demansında damarsal risk faktörleri değerlendirmesi: klinik deneyimimiz

Pages
53–58
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, further clinical prospective studies with larger patient groups are needed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by a progressive and irreversible deterioration of memory and cognitive functions and is the leading cause of senile dementia.
📊
Key Findings & Data:Findings: A total of 111 patients with Alzheimer’s disease, registered in Dementia Unit in Tepecik Research and Training Hospital were included in the study.
💡
Conclusion & Impact:Thus, further clinical prospective studies with larger patient groups are needed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by a progressive and irreversible deterioration of memory and cognitive functions and is the leading cause of senile dementia. Recently, there is increasing evidence sug- gesting a role for vascular risk factors in disease pathogenesis. The aim of this study is to investigate the frequency of vascu- lar risk factors and their correlation with the disease severity in the patients with Alzheimer’s disease in our clinic. Material and Method: Information of demographic features such as age, gender, education and vascular risk factors with fasting plasma total cholesterol, LDL, HDL and triglycerides were gathered from the patient registry retrospectively. The cor- relation between these features and Mini Mental State Examination (MMSE) score, indicating the disease severity, were evaluated. Findings: A total of 111 patients with Alzheimer’s disease, registered in Dementia Unit in Tepecik Research and Training Hospital were included in the study. No correlation between demographic features, vascular risk factors and the severity of disease were found (p>0.05). HDL cholesterol was found to be negatively correlated with MMSE score (t:-2.38, 95%CI: - 0.19; -0.02, p: 0.019), but total cholesterol, LDL and triglycerides were not correlated with the disease severity. Conclusion: Our study implies the role of HDL cholesterol in AD pathogenesis in concordance with the previous studies. Iis crucial to clarify the disease pathogenesis and risk factors of AD in order to identify the under risk individuals and early diagnose the disease. Thus, further clinical prospective studies with larger patient groups are needed.

Özet

Amaç: Alzheimer Hastalığı (AH), hafıza ve bilişsel yetilerin ilerleyici ve geri-dönüşsüz kaybı ile karakterize nörodejeneratif bir hastalıktır ve ileri yaşta demansın en önemli nedenidir. Son yıllarda vasküler risk faktörlerinin de AH patogenezinde önemli rolü olduğu ileri sürülmektedir. Bu çalışmanın amacı kliniğimizdeki Alzheimer hastalarında damarsal risk faktörleri- nin sıklığının ve hastalıkla ilişkisinin araştırılmasıdır. Gereç ve Yöntem: Geriye dönük dosya taraması yöntemi ile AH olan hastaların yaş, cinsiyet, eğitim durumu gibi demogra- fik özellikleri ve vasküler risk faktörü bilgileri ile serum açlık lipid düzeyleri taranmış ve hastalık şiddetinin bir izlem göster- gesi olan Mini Mental Durum Değerlendirme Testi (MMT) ile olan ilişki incelenmiştir. Bulgular: Çalışmaya alınan 111 hastanın gerek demografik özellikleri gerekse de vasküler risk faktörleri ile MMT arasında anlamlı bir ilişki saptanmamıştır (p>0.05). Plazma açlık lipid düzeyleri ile MMT arasındaki korelasyona bakıldığında ise, total kolesterol, LDL ve trigliserid düzeyleri ile MMT arasında anlamlı bir ilişki saptanmazken, HDL kolesterolün artışı ile MMT skorunun istatistiksel olarak anlamlı şekilde azaldığı (t:-2.38, 95%CI: -0.19; -0.02, p: 0.019) izlenmiştir. Sonuç: Bu bulgular HDL kolesterolün AH klinik şiddeti ile ilişkili olduğunu göstermesi bakımından değerlidir ve HDL ko- lesterolün AH patogenezinde rolü olduğunu desteklemektedir. Alzheimer hastalığının erken tanısı ve risk altındaki bireylerin tanınması için hastalığın risk faktörlerinin ve patogenezinin daha net bir şekilde aydınlatılması gereklidir. Bu nedenle daha geniş hasta grupları üzerinde bu konuda planlanacak ileriye dönük klinik çalışmalara gerek vardır.

🔖

Cite This Article

TİFTİKCİOĞLU, B. İ., TUNÇAY, N., KORUCUK, M., ZORLU, Y. (2012). Evaluatıon of vascular rısk factors ın alzheımer’s dementıa: clınıcal experıence. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 22 - Sayı: 1, 53–58. https://ajindex.com/articles/268399

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K et al. Alzheimer's disease and vascular dementia in de- veloping countries: prevalence, management, and risk factors. Lancet Neurol 2008; 7(9):812-26.
  2. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey- Bloom J, Relkin N et al. Practice parameter: diagnosis of de- mentia (an evidence-based review). Report of the Quality Stan- dards Subcommittee of the American Academy of Neurology. Neurology 2001; 56(9):1143-53.
  3. Chui HC, Zheng L, Reed BR, Vinters HV, Mack WJ. Vascular isk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that ncreases the likelihood of dementia? An evidence-based re- view. Alzheimers Res Ther 2012; 4(1):1. Knopman DS, Penman AD, Catellier DJ, Coker LH, Shibata DK, Sharrett AR et al. Vascular risk factors and longitudinal changes on brain MRI: the ARIC study. Neurology 2011; 76(22):1879-85. Launer LJ. Demonstrating the case that AD is a vascular dis- ease: epidemiologic evidence. Ageing Res Rev 2002; 1(1):61- 77. Dede DS, Yavuz B, Yavuz BB, Cankurtaran M, Halil M, Ulger Z et al. Assessment of endothelial function in Alzheimer's dis- ease: is Alzheimer's disease a vascular disease? J Am Geriatr Soc 2007; 55(10):1613-7.
  4. Yavuz BB, Dede DS, Yavuz B, Cankurtaran M, Halil M, Ulger Z et al. Potential biomarkers for vascular damage in Alz- heimer's disease: thrombomodulin and von Willebrand factor. J Nutr Health Aging 2010; 14(6):439-41.
  5. Folstein MF, Robins LN, Helzer JE. The Mini-Mental State Examination. Arch Gen Psychiatry 1983; 40(7):812. American Psychiatric Association. Diagnostic criteriaDSM-IV-TR. Washington, D.C: The Association; 2000.
  6. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alz- heimer's Disease. Neurology 1984; 34(7):939-44.
  7. Solfrizzi V, Panza F, Colacicco AM, D'Introno A, Capurso C, Torres F et al. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 2004; 63(10):1882-91.
  8. Merched A, Xia Y, Visvikis S, Serot JM, Siest G. Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease. Neurobiol Aging 2000; 21(1):27-30.
  9. Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P et al. Serum